Supplement: TX SB403 | 2023-2024 | 88th Legislature | Fiscal Note (Introduced)
For additional supplements on Texas SB403 please see the Bill Drafting List
Bill Title: Relating to a study on the adverse reactions and efficacy of COVID-19 vaccines.
Status: 2023-05-23 - Committee report sent to Calendars [SB403 Detail]
Download: Texas-2023-SB403-Fiscal_Note_Introduced_.html
Bill Title: Relating to a study on the adverse reactions and efficacy of COVID-19 vaccines.
Status: 2023-05-23 - Committee report sent to Calendars [SB403 Detail]
Download: Texas-2023-SB403-Fiscal_Note_Introduced_.html
| TO: |
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services |
| FROM: |
Jerry McGinty, Director, Legislative Budget Board
|
| IN RE: |
SB403 by Springer (Relating to a study on the side effects, adverse reactions, including death, and the effectiveness of vaccines against the SARS-CoV-2 virus (COVID-19) or its variants.), As Introduced |
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
| Source Agencies: | 529 Health and Human Services Commission, 537 State Health Services, Department of |
| LBB Staff: | JMc, NPe, ER, APA |
